Spots Global Cancer Trial Database for Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Official Title: A Phase 2, Multicenter Randomized Controlled Open-label Study of Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Study ID: NCT06241781
Conditions
Study Description
Brief Summary: This is a Phase II, multicenter, open-label, randomized, parallel group, treatment study to assess the efficacy and safety of Autologous Tumor Infiltrating Lymphocytes (GT101 injection) compared with Gemcitabine in participants with recurrent or metastatic cervical cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
The Fifth Medical Center of the General Hospital of the People's Liberation Army of China, Beijing, Beijing, China
Fujian Cancer Hospital, Fuzhou, Fujian, China
Chinese Academy of Medical Sciences Cancer Hospital Shenzhen Hospital, Shenzhen, Guangdong, China
Guangxi Medical University Affiliated Cancer Hospital, Guilin, Guangxi, China
Harbin Medical University Affiliated Cancer Hospital, Ha'erbin, Heilongjjiang, China
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Xiangya Second Hospital of Central South University, Changsha, Hunan, China
Southeast University Affiliated Zhongda Hospital, Nanjing, Jiangsu, China
Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, China
Affiliated Zhongshan Hospital Dalian University, Dalian, Liaoning, China
Dalian Medical University First Affiliated Hospital, Dalian, Liaoning, China
Shandong First Medical University Affiliated Cancer Hospital, Jinan, Shandong, China
Jining First People's Hospital, Jining, Shandong, China
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Fudan University Affiliated Obstetrics and Gynecology Hospital, Shanghai, Shanghai, China
Shanxi Cancer Hospital, Taiyuan, Shanxi, China
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China
Sichuan University West China Second Hospital, Chengdu, Sichuan, China
Yibin Second People's Hospital, Yibin, Sichuan, China
Tianjin Cancer Hospital, Tianjin, Tianjin, China
Yun Cancer Hospital, Kunming, Yunnan, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
